Cancer Videos

New treatments should be safe for everyone, but data shows that trials don't reflect the makeup of the general population. Here's why that needs to change.

Trials are always testing new drugs as a first-line treatment. Some even result in the new standard of care.

No, you will not be a guinea pig. Explore this and two other myths that are barriers to taking part in clinical trials.

How do the three phases of a clinical trial compare to each other?

Don't be afraid to ask for help during treatment. There are many resources available, not only for patients, but for families and caregivers, too.

Some factors you can change, and others you can't. The key is knowing where you stand and doing everything you can to prevent cancer.

Certain foods help with cancer prevention, while others hurt. Here's what to stock up on and what to limit.

What percentage of cases is caused by inherited mutations? And what do screenings tell us?

Cancer screenings are essential for prevention, so it's important to follow guidelines and understand what average risk means.

More than 600 cancer medications have been approved in the last two decades, says Pavani Chalasani, MD. So just imagine what's on the horizon, especially in targeted therapies.

Swapping the word "prevention" for "risk reduction" emphasizes the need to adopt healthy habits like not smoking and watching your weight.

The reasons behind disparity in cancer cases aren't black and white. There's more at play than genetics in why Black Americans have more aggressive tumors younger.

Sunil Verma, MD, of AstraZeneca envisions the future of cancer care, including the role of AI and streamlining screening guidelines.

Elcin Barker Ergun, CEO of the Menarini Group, talks about a renewed interest in drug development to address unmet needs while shaping policy.

On the heels of its annual meeting, ASCO president Robin Zon outlines the organization's goals, including the use of AI in cancer treatment.

Lykke Hinsch Gylvin, MD, the chief medical officer of Boehringer Ingelheim, talks about patient centricity and AI as it relates to drug development.

Screenings have cut cancer rates, but there’s a lot of work to be done when it comes to awareness, disparities, and vaccines, author Bruce Ratner says.

Talk with your doctor about how medications may affect your lifestyle and what side effects to expect. Ask about new therapies on the market, as well.

Depending on your type, your doctor may recommend surgery or radioactive iodine ablation. Learn about the different treatments.

Patrick Dempsey, People magazine’s “Sexiest Man Alive,” founded free cancer centers in Maine. They honor his mom’s battle and provide a sense of community.

Robert Brodsky, MD, thinks back on his year as president of the American Society of Hematology and the latest advances in treating blood disorders.

Not everyone has equal access to tests that pinpoint genetic conditions. Why the inequality? And what’s being done to bridge the gap?

Could liquid biopsies detect cancer sooner? Sanjay Juneja, MD, discusses how they differ from at-home genetic tests like 23andMe.

Explore King Hussein Cancer Center's approach to cancer care in Amman. See how they use research, education, and patient care to transform treatment.

AstraZeneca's David Fredrickson is encouraged by the latest cancer research and discusses the four Ps: Policy, Politics, Priorities, and Prevention.

Lynn Matrisian, PhD, MBA, Chief Science Officer of the Pancreatic Cancer Action Network (PanCAN), shares her insights on the steady increase in the five-year survival rate for pancreatic cancer.

Samantha Harris of "Dancing With the Stars" fame credits restorative yoga with helping her recover after breast cancer surgery.

Fabrice Barlesi, MD, PhD, general director of Institut Gustave Roussy, one of the world's leading cancer centers, discusses Europe's approach to cancer treatment and prevention.

WebMD's Chief Medical Officer, John Whyte, MD, speaks with Sanjay Juneja, MD, Chief of Oncology, Baton Rouge General Hospital, about multiple strategies and treatments for cancer and why the phrase "a cure for cancer" might be outdated.

A surgeon outlines advances in cancer treatments, touching on “the three t’s: timing, technique, and technology.”

From dried wolf’s tongue to immunotherapy, we’ve come a long way in the treatment of cancer. Centuries of progress in killing cancer cells.

Which group has the highest cancer death rate? We break it down by cancer type and race/ethnicity.

Certain groups have a higher cancer rate than others, depending on things like race and income. So what’s being done to broaden access to better care?

Information is key before participating in a clinical trial, so ask your doctor about the goal of the study and consider all the possible outcomes.

WebMD's Chief Medical Officer, John Whyte, MD, outlines four key ways to lower your risk of cancer, taken from his new book, "Take Control of Your Cancer Risk."

WebMD's Chief Medical Officer, John Whyte, MD, speaks with Michael Byas-Smith, MD, Medical Director, Capital Caring Schaufeld Family Advanced Pain Clinic, about managing cancer pain with alternative interventional therapies.

WebMD's Chief Medical Officer, John Whyte, MD, speaks with Caryn Freiberger, organizer of the Gotham Gymnastics Handstand Walk with Eloise, about her initiative to raise funds and awareness for pediatric cancer research.

WebMD's Chief Medical Officer, John Whyte, MD, speaks with Lynn Matrisian, PhD, MBA, chief science officer of the Pancreatic Cancer Action Network (PanCAN), about new screening tests for pancreatic cancer and the hope of finding this hard-to-diagnose condition earlier.

HRH Princess Ghida Talal, a champion of cancer research and prevention, gives John Whyte, MD, MPH, chief medical officer at WebMD, insight into the international fight.

Historically, there were three treatments for cancer: radiation, chemotherapy, and surgery. A fourth option, immunotherapy, has grown in scope and capability in the past 20 years.

John Whyte, MD, chief medical officer at WebMD, and gastroenterologist Paul Limburg, MD, talk about the incredible advances in cancer screenings over the past several years, especially for colorectal cancers.

Genomic testing is a relatively new process that allows a tumor to be tested to look for mutations that are driving the cancer’s growth.

Targeted drugs can be tailored based on your specific cancer, allowing for much more precise treatment.